DelveInsight’s “Chronic Obstructive Pulmonary Disease Pipeline Insight 2026” report provides comprehensive insights about 65+ companies and 75+ pipeline drugs in the Chronic Obstructive Pulmonary Disease pipeline landscape. It covers the
Press Release
DelveInsight’s “CAR T-Cell Therapy Pipeline Insight 2026” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in the CAR T-Cell Therapy pipeline landscape. It covers the CAR T-Cell
DelveInsight’s “Atopic Dermatitis Pipeline Insight 2026” report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in the Atopic Dermatitis pipeline landscape. It covers the Atopic Dermatitis Pipeline drug
DelveInsight’s, “Alzheimer’s disease Pipeline Insight, 2026” report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in Alzheimer’s disease pipeline landscape. It covers the Alzheimer’s Disease pipeline drug profiles,
Emerging Next Generation Immunotherapies therapies including OPDUALAG (relatlimab/nivolumab), Fianlimab (REGN-3767), Cobolimab (GSK-4069889), Tiragolumab (RG-6058), Ezabenlimab (BI-754091), and others are driving
DelveInsight’s, “Alopecia Areata Pipeline Insight 2026” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Alopecia Areata
The market dynamics for Diabetic Neuropathic Pain are witnessing steady growth driven by the rising prevalence of diabetes, increasing burden
The market dynamics for EGFR Inhibitors-induced Skin Disorders are witnessing significant growth driven by the increasing use of EGFR inhibitors
The market dynamics for Actinic Keratosis are witnessing substantial growth driven by the increasing prevalence of chronic sun exposure-related skin
The Key Gene and Cell Therapies Targeting CNS Disorders Companies in the market include – In8bio Inc., Brainstorm Cell Therapeutics,
